AzTrials
AzTrials

Patellar TendinopathyNCT07095738

Textural Analysis and Effect of ROI Size on Infrared Thermography in Athletes With Patellar Tendinopathy

An observational study of Patellar Tendinopathy and Diagnostic Accuracy, run by Cardenal Herrera University at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patellar tendinopathy (PT) is a common knee disorder, particularly among elite athletes, with a reported prevalence of approximately 14.2%. Athletes affected by PT may experience persistent pain, functional impairment, reduced quality of life, decreased physical performance, and even premature career termination. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
What is being tested?
thermal images (IT)
How many people
54 participants
Where
1 siteSpain
Study dates
1 Aug 2025to 19 Sep 2025
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: All participants will be instructed not to engage in physical exercise; not to drink alcohol, coffee, or energy drinks 12 hours prior to measurements; not to smoke in the 6 hours prior to measurements; not to apply creams or lotions to their legs to avoid altering skin emissivity; to report any medication or treatments they were taking; and to try to avoid altering their rest and meal habits. These requirements minimise the influence of individual extrinsic factors on the IT results.

Who may be able to join

  • Specific functional tests.
  • Ultrasound evaluation.
  • Symptom evolution time of more than 3 months.
  • A VISA-P score of less than 80.
  • The performance of a differential diagnosis to rule out other potential causes of anterior knee pain.

Who cannot join

  • Lower limb pathology.
  • Nerve or vascular disorder, or skin lesion in the knee area that could alter thermal information in the patellar tendon region.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Ceu Cardenal Herrera University

    Elche, Alicante, 03204

Other trials in Spain

About this study

Official title: Textural Analysis and Effect of ROI Size on Infrared Thermography in Athletes With Patellar Tendinopathy. A Cross-sectional Study

Patellar tendinopathy (PT) is a common knee disorder, particularly among elite athletes, with a reported prevalence of approximately 14.2%. Athletes affected by PT may experience persistent pain, functional impairment, reduced quality of life, decreased physical performance, and even premature career termination. Diagnosing PT remains challenging due to the absence of a gold standard diagnostic method. Although imaging techniques such as ultrasonography (US) and magnetic resonance imaging (MRI) can aid in confirming the diagnosis and assessing severity, MRI is costly and less accessible, and US shows poor correlation with clinical symptoms. Consequently, diagnosis largely relies on clinical examination and medical history. Infrared thermography (IT) has emerged as a potential alternative imaging technique, offering a low-cost, reliable, and non-invasive method to detect thermal asymmetries indicative of underlying pathologies. Technological advancements have enhanced the precision of IT, reducing the thermal asymmetry threshold from 2-3 ºC in the 1970s to 0.5 ºC in current knee assessments. First-order statistics, such as mean gray intensity, and second-order features based on the gray-level co-occurrence matrix (GLCM), have been extensively used in medical image analysis, including IT, to quantify structural and textural characteristics. The size of the region of interest (ROI) is also a critical factor in thermal and texture analyses, as it can influence sensitivity and diagnostic accuracy. Given these considerations, the objectives of this study were: (1) to evaluate differences in thermal and GLCM-based textural features between athletes with PT and healthy controls; (2) to compare the diagnostic performance of IT and GLCM features applied to thermographic images; and (3) to identify the most appropriate ROI size for optimal characterization of PT using both thermal and textural analysis.

Being tested
thermal images (IT)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • thermal images (IT)Diagnostic test

    The IT images were recorded with an OPTRIS PI 450 IRT camera coupled to Optris PI Connect Software (Germany). The IRT camera has a Noise Equivalent Temperature Difference <40 mK with 38º x 29º FOV, a wide range of temperature from -20°C to +100°C, spectrum range of 7.5-13 μm, focal plane array sensor size of 382 × 288 pixels, emissivity set at 0.98 and a measurement uncertainty of ± 2% of the overall temperature reading. The size of the capture frame will be 55.4 × 40.63 cm (1.5 mm/px).

Study groups in NCT07095738
Study groupRoleWhat they receive
athletes with unilateral PTdiagnosed through a combination of clinical criteria, specific functional tests, and ultrasound evaluation. Additional inclusion criteria for this group include a symptom evolution time of more than 3 months, a VISA-P score of less than 80, and the performance of a differential diagnosis to rule out other potential causes of anterior knee pain
Receives: Diagnostic Test: thermal images (IT)
healthy volunteer athletesrecruited under the inclusion criteria of no previous history of PT and a VISA-P score of 100
Receives: Diagnostic Test: thermal images (IT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Textural analysis based on the Gray-Level Co-occurrence Matrix (GLCM)

    GLCM relies on the angular relationship between neighboring pixels and the distance between them. relies on the angular relationship between neighboring pixels and the distance between them.

    Measured: baseline

  2. Energy or angular second moment (ASM)

    ASM Measures the uniformity or regularity in the distribution of image values. Higher values indicate greater uniformity in the image.

    Measured: baseline

  3. Homogeneity or inverse difference moment (IDM)

    IDM reflects the homogeneity of image composition, associated with pixel pairs. Homogeneous images with minimal variations produce high IDM values

    Measured: baseline

  4. Contrast (CON)

    CON represents the degree of local variations in gray levels within the image.If the variation increases, the contrast increases.

    Measured: baseline

  5. Textural correlation (TCOR)

    TCOR expresses linear dependencies between gray levels in the image. Regions with similar gray levels tend to exhibit higher values.

    Measured: baseline

  6. Entropy (ENT)

    Indicates the level of disorder within the image. Homogeneous images result in lower entropy values

    Measured: baseline

Secondary outcomes (4)
  1. Age (years)

    Measured: baseline

  2. Sex

    Measured: baseline

  3. Body Mass index (BMI)

    kg/m²

    Measured: baseline

  4. time of evolution (months)

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jul 2025
  2. Study start1 Aug 2025
  3. Primary completion20 Aug 2025
  4. Study completion19 Sep 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
54 participants (actual)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT07095738
Sponsor's protocol ID
CE111803
Status last verified
Sep 2025
First submitted
23 Jul 2025
Last updated
24 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data associated with this paper will be available in the Zenodo repository

Questions about this trial

What is this clinical trial studying?

An observational study of Patellar Tendinopathy and Diagnostic Accuracy, run by Cardenal Herrera University at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Textural analysis based on the Gray-Level Co-occurrence Matrix (GLCM) (time frame: baseline). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in